Search results
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via AOL· 6 days ago"I want to see early signs next year," he said. Still, whether this new partnership will indeed one...
Merck to Buy Eye-Focused Drug Developer EyeBio for as Much as $3 Billion
US News & World Report· 6 days agoThe deal is the latest in a string of recent acquisitions by Merck to reduce its reliance on blockbuster immunotherapy Keytruda, which is expected to face rivals by the end ...
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 5 days agoSolid corporate earnings and rate cut bets have been driving stocks higher. In particular, NVIDIA's ...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 6 days agoOver this period, the company intends to launch 20 new medicines, a number of which supposedly have...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 6 days agoIf everything goes as planned, the company will produce at least eight new blockbuster medicines...
Meet Nvidia CEO Jensen Huang, whose net worth just cracked $100 billion
Business Insider via Yahoo News· 6 days agoHuang's personal fortune of $100 billion now puts him 15th on the outlet's Billionaires...
Tencent’s Marquee Game Generates Over $140 Million in First Week
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Tencent Holdings Ltd.’s blockbuster release Dungeon & Fighter Mobile is estimated to...
Every Will Smith Movie Ranked, According To Metacritic
GameSpot· 13 hours agoWill Smith is one of Hollywood's most iconic and accomplished actors. Smith is also known for...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 1 day agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
5 Top Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoThanks mainly to its CF therapy Trikafta, the company generated revenue of $2.69 billion and a profit of nearly $1.1 billion in the first quarter of...